Research suggests the possibility of a more general phenomenon, applicable to the growth of other primary cell types.
Ian Demsky is a senior writer and public relations representative for the University of Michigan Rogel Cancer Center. Ian joined the cancer center communications team in 2019. Prior to that he served as director of communications for the U-M Life Sciences Institute and science editor for Medicine at Michigan Magazine.
In mouse models, the work uncovers a new potential target to improve immunotherapy approaches to the deadly disease.
Proof-of-concept research points to wearable monitors’ potential to offer low-cost, non-invasive way to detect this dangerous bone-marrow transplant complication.
An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.
A potent and selective degrader of the transcription factor STAT3 offers a new approach to a previously “undruggable” target.